NEW YORK, July 6 (Reuters) - Cronos Group Inc (CRON.TO), the Canadian cannabis producer backed by cigarette maker Altria Group Inc (MO.N), is exploring options that include a potential sale after attracting acquisition interest, people familiar with the matter said.
Shares of Cronos jumped as much as 25% in Toronto on the news, giving the company a market value of C$1.03 billion ($771.13 million).
For the first quarter, Cronos posted a net loss of $19.3 million, compared with a loss of $32.7 million a year ago.
Cronos has total cash, including short-term investments, of about $836.43 million, according to its first-quarter report.
Altria, which holds a 41% stake in Cronos, invested $1.8 billion in the company in 2019.
Persons:
Altria, Cronos, Joe Biden's, Anirban Sen, Abigail Summerville, Leslie Adler, Richard Chang
Organizations:
YORK, Cronos, Altria, Curaleaf Holdings, U.S, Thomson
Locations:
Toronto, U.S, North America, Cronos, New York